View all IPCC CME

Share a PER® activity with your colleagues or friends. Connect with the PER® social network.



Accreditation/ Credit Designation

Physicians' Education Resource®, LLC, (PER®) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.


Resources

PER Pulse™ Recaps
for Community Practice Connections™: New York GU™: 9th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies focuses on areas of clinical challenge faced by practicing oncologists. A brief overview of expert perspectives on case management decisions is provided in these summaries.


Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie Inc, Astellas, Bayer, Genomic Health, Inc., Novartis Pharmaceuticals Corporation, and Sanofi US.


Community Practice Connections™: New York GU™: 9th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies


Release Date: May 27, 2016
Expiration Date: May 27, 2017
Media: Internet - based

Activity Overview

Community Practice Connections™: New York GU™: 9th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies consists of a series of interactive clinical vignettes, short video interviews of leading experts in the management of prostate cancer, renal cell carcinoma, and bladder cancer. The activity also features short evidence-based summaries directly related to the treatment of these malignancies. The video interviews address key issues and clinical cases presented and discussed at New York GU™: 9th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies.

CME Activity Table of Contents

  • Immunotherapy for Urothelial Bladder Cancer
    Daniel P. Petrylak, MD
     
  • Early Prostate Cancer: Screening and Molecular Markers
    Leonard G. Gomella, MD, FACS
     
  • Advanced Castration-Resistant Prostate Cancer: Chemotherapy
    Daniel P. Petrylak, MD
     
  • Castration-Resistant Prostate Cancer with Bone Metastases
    A. Oliver Sartor, MD
     
  • Metastatic Renal Cell Carcinoma
    Toni K. Choueiri, MD
     
  • Immunotherapy for Renal Cell Carcinoma
    Mario Sznol, MD

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.


Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with genitourinary (GU) malignancies. Urologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, nuclear medicine physicians, and other healthcare professionals interested in the treatment of GU malignancies may also participate.


Educational Objectives

At the conclusion of this activity, you should be better prepared to:
  • Describe methods to stratify risk and tumor information that can provide the rationale for clinical decision making in the management of genitourinary (GU) malignancies
  • Summarize recommendations that shape current strategies to care for patients with GU malignancies
  • Develop multidisciplinary strategies to optimize outcomes by proactive mitigation of known treatment-related side effects in caring for patients with GU malignancies
  • Assess recent practice-changing clinical trial findings concerning novel compounds or strategies to manage GU malignancies
  • Apply emerging clinical concepts to support the management of GU malignancies in consideration of evolving treatment paradigms in the field


Faculty, Staff, and Planners' Disclosures

Co-Chairs

Leonard G. Gomella, MD, FACS
The Bernard W. Godwin Jr. Professor of Prostate Cancer
Chairman, Department of Urology
Senior Director, Clinical Affairs, Sidney Kimmel Cancer Center
Clinical Director, Jefferson Sidney Kimmel Cancer Network
Thomas Jefferson University
Philadelphia, PA

Daniel P. Petrylak, MD
Professor of Medicine, Medical Oncology
Director, Prostate and GU Medical Oncology
Director, Prostate Cancer Translational Research Group
Yale Cancer Center
New Haven, CT



Faculty

Toni K. Choueiri, MD
Director, Kidney Cancer Center
Clinical Director, Lank Center for Genitourinary Oncology
Department of Medical Oncology
Dana-Farber Cancer Institute/Brigham and Women's Hospital
Associate Professor of Medicine, Harvard Medical School
Boston, MA

A. Oliver Sartor, MD
Medical Director, Tulane Cancer Center
Associate Director for Clinical Programs
Tulane Cancer Center C.E. and Bernadine Laborde Professor of Cancer Research
Professor, Department of Medicine
Section of Hematology & Medical Oncology and Department of Urology
Member, Tulane Cancer Center Program
Tulane University Medical School
New Orleans, LA
 

Mario Sznol, MD
Professor of Medicine (Medical Oncology)
Yale School of Medicine
Clinical Research Program Leader, Melanoma Program
Co-Director, Yale SPORE in Skin Cancer
Yale Cancer Center
New Haven, CT
 

The following individuals have no relevant financial relationships with commercial interests to disclose:

The staff of Physicians’ Education Resource®, LLC (PER®)

The following individuals have no relevant financial relationships with commercial interests to disclose:

Toni K. Choueiri, MD – Grant/Research Support (all money to institution): Pfizer, GSK, Novartis, BMS, Merck, Exelixis, Roche, AstraZeneca, Tracon; Consultant: Pfizer, GSK, Novartis, Bayer, Eisai, Bristol-Myers Squibb, Merck, Roche, Prometheus Labs; Leonard G. Gomella, MD, FACS – Grant/Research Support: Astellas, Janssen; Consultant: Bayer, Astellas, Janssen, MDxHealth; Other Support: NRG (RTOG); Daniel P. Petrylak, MD – Grant/Research Support: OncoGenex, Progenics, J&J, Millennium Pharmaceuticals, Celgene, Dendreon, Sanofi; Consultant: Bayer, Bellicum, Dendreon, sanofi-aventis, J&J, Exelixis, Ferring, Millennium Pharmaceuticals, Medivation, Pfizer; A. Oliver Sartor, MD – Grant/Research Support: Algeta, AstraZeneca, Cougar Biotechnology, GSK, J&J, sanofi-aventis; Consultant: Algeta, Amgen, Bayer, Bellicum, Bristol-Myers Squibb, Celgene, Dendreon, Exelixis, GSK, JNJ, Medivation, OncoGenex, Sanofi; Shareholder: GSK, JNJ, Lilly; Mario Sznol, MD – Consultant: Genentech-Roche, Bristol-Myers Squibb, AstraZeneca/MedImmune, Pfizer, Novartis, Kyowa Hakko Kirin, Amgen (none in past 12 months), Merus, Seattle Genetics, Immune Design, Prometheus, Anaeropharma Science, Astellas-Agensys, Immunova (no fees to date), Nektar Therapeutics, NeoStem, Laboratoires Pierre Fabre (not paid); Scientific Advisory Board (paid): Lion Biotechnologies, Symphogen; Shareholder: stock options for Amphivena, Adaptive Biotechnologies


Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of Physicians' Education Resource®, LLC, (PER®) to ensure fair balance, independence, objectivity, and scientific rigor in all of our CME/CE activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as a part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.


Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of Physicians' Education Resource®, LLC, or any of the companies that provided commercial support for this activity.


Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise




Calendar of Events
SUNMONTUESWEDTHURSFRISAT
1234567
891011121314
15161718192021
22232425262728
293031
Filter By